Diagnostics Research Group
IMA Clinical Research (Diagnostics Research Group) is a US-based clinical trial site network operating 15+ satellite sites across 10 states with a 400K+ patient database, providing site-based, hybrid, and decentralized trial services to pharmaceutical sponsors and CROs across therapeutic areas including depression, obesity, MASH, and memory loss.
- Company typePrivate
- Founded2000
- HeadquartersSan Antonio, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Diagnostics Research Group does
IMA Clinical Research Inc., doing business as Diagnostics Research Group and IMA Clinical Research, is a US-based clinical trial site network founded in 2000 and headquartered in Tarrytown, New York. The company operates 15+ satellite clinical trial sites across 10 states supported by 150+ full-service site locations, with a 400K+ patient database and 10K+ unique weekly patient visits. It runs site-based, hybrid, and fully decentralized clinical trials across four core therapeutic areas: depression, obesity, metabolic liver disease (MASH/NASH), and memory loss.
The platform's underlying technology is operational rather than software-centric: flexible patient outreach centers that can be deployed wherever and whenever needed, patient-centric technology supporting remote participation, and a large proprietary patient database enabling efficient enrollment of qualified, diverse participants. The company offers free liver scans and participant compensation for time and travel as patient-side recruitment tools.
Revenue is generated through professional services contracts with pharmaceutical sponsors and Contract Research Organizations (CROs), structured as per-enrolled-participant compensation with additional payments for specific trial milestones and procedures. The company sells to two customer segments: pharmaceutical sponsors and CROs (the primary enterprise revenue source) and patients (a recruitment channel, not a revenue stream). Go-to-market combines direct enterprise field sales with sponsor-facing thought leadership (webinars, ACRP conference participation, knowledge center content) and patient-facing community outreach (referral programs, social media, phone-based outreach centers).
Diagnostics Research Group firmographics
Firmographics- Name
- Diagnostics Research Group
- Legal name
- IMA Clinical Research Inc.
- Website
- https://dxrg.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IMA Clinical Research (Diagnostics Research Group) is a US-based clinical trial site network operating 15+ satellite sites across 10 states with a 400K+ patient database, providing site-based, hybrid, and decentralized trial services to pharmaceutical sponsors and CROs across therapeutic areas including depression, obesity, MASH, and memory loss.
- Ownership category
- akta.pro rank
Diagnostics Research Group industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
Keywords
Where Diagnostics Research Group is headquartered
LocationHeadquarters
- HQ city
- San Antonio
- HQ country
- United States
- HQ region
- North America
Offices15 records
Markets served
Diagnostics Research Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Trial Services Contracts: Revenue generated through contracts with pharmaceutical sponsors and Contract Research Organizations (CROs) for conducting clinical trials. Compensation is provided for each enrolled participant, with additional payments for specific trial milestones and procedures performed.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Diagnostics Research Group product offering
Product offeringCore offering
Diagnostics Research Group operates the IMA Clinical Research Network, a flexible clinical trial network that conducts site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs across multiple therapeutic areas including depression, obesity, MASH (metabolic liver disease), and memory loss. The network spans 15+ satellite sites and 150+ total locations in the U.S., supported by a 400K+ patient database with 10K+ unique weekly visits and deployable patient outreach centers.
Product overview
IMA Clinical Research operates a flexible clinical trial network offering site-based, hybrid, and fully decentralized clinical trials. The network includes full-service clinical trial sites and 15+ nationwide satellite sites with over 10,000 unique weekly visits and access to 400K+ patient database. The platform provides patient-centric technology supporting flexible trial models with deployable patient outreach centers. Therapeutic areas include depression, obesity, liver/MASH, and memory loss clinical trials.
Differentiator
Problem solved
Functional benefit
Products and services
- IMA Clinical Research Network Flexible clinical trial network offering site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs, comprising full-service sites and 15+ nationwide satellite sites with access to a 400K+ patient database.
- Site-Based Clinical Trials Traditional in-person clinical trial conduct at full-service clinical trial sites located across multiple states including Arizona, Florida, Illinois, Louisiana, North Carolina, New Jersey, New Mexico, Nevada, New York, and Texas.
- Hybrid Clinical Trials Combination of site-based and remote participation options, allowing flexible trial conduct with patient outreach centers set up wherever and whenever needed.
- Fully Decentralized Clinical Trials Remote clinical trial participation options enabled through patient-centric technology, reaching patients regardless of geographic location.
- Patient Outreach Centers Flexible patient outreach centers deployed wherever and whenever needed to support clinical trial recruitment and expand access to participants across the United States.
- Depression Clinical Trials Clinical trials for depression currently enrolling patients in Hickory NC, Monroe LA, Albuquerque NM, Phoenix AZ, and Las Vegas NV, with compensation offered to participants for time and travel.
- Obesity Clinical Trials Clinical trials for obesity enrolling in Warren NJ, St. Petersburg FL, Austin TX, San Antonio TX, Lenoir NC, and Monroe LA, with compensation offered for time and travel.
- Liver/MASH Clinical Trials Clinical trials for metabolic-associated steatohepatitis (MASH) with free liver scans for individuals with BMI over 27, enrolling in Austin TX, San Antonio TX, Warren NJ, New York City NY, and Westchester NY.
- Memory Loss Clinical Trials Clinical trials for memory loss enrolling adults 55 and older with compensation offered for time and travel, currently enrolling in Albuquerque NM and San Antonio TX.
Quantifiable outcome
- 400K+ patient database with 10K+ unique weekly visits
- +1 more outcomes
Companies that use Diagnostics Research Group
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles1 record
Diagnostics Research Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Diagnostics Research Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- ACRP (Association of Clinical Research Professionals)minorProfessional association for clinical research professionals. IMA Clinical Research staff actively participate in ACRP events and conferences (e.g., ACRP 2026), demonstrating ongoing professional relationship and industry engagement.
- AMRC (Albuquerque Medical Research Center)minorAMRC is listed as an affiliated organization, with the Albuquerque Neurosciences site operating under this partnership. Represents strategic alignment in the clinical research network.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Diagnostics Research Group competitors and assessment
Company assessmentDirect peers
- Velocity Clinical Research: National multi-therapeutic clinical trial site network offering site-based, hybrid, and DCT options to sponsors/CROs; directly comparable to IMA in model, therapeutic areas, and customer base.
- CenExel Clinical Research: Multi-site SMO focused on specialty Phase 2–4 trials in CNS, metabolic, pain, and other indications; operates a comparable single-tenant site-network model with sponsor-direct contracts.
- Flourish Research: Independent clinical research site network with multiple US locations enrolling in obesity, MASH, CNS, and cardiometabolic trials; closely mirrors IMA's therapeutic breadth and hybrid/DCT positioning.
- DM Clinical Research: Multi-specialty Texas-based SMO with a large patient database and broad therapeutic-area coverage; comparable footprint, geography, and sponsor/CRO contract model.
- Clinical Trials of Texas: San Antonio-anchored independent research site network; like IMA it operates Texas-based sites and enrolls in obesity, MASH, and CNS trials, making it a close regional peer.
- Accel Research Sites: Florida-headquartered SMO network running Phase 1–4 trials across multiple therapeutic areas with a comparable sponsor-direct clinical trial services model.
- Benchmark Research: Independent multi-therapeutic clinical research site organization with a similar mix of CNS, metabolic, and infectious-disease trials for pharma sponsors.
Broad incumbents
- IQVIA (Site Management): Global CRO with embedded site-network capabilities serving the same large-pharma sponsors as IMA; not a head-to-head competitor in niche independent-site deals but competes at the enterprise level.
- Thermo Fisher Scientific (PPD): Large CRO offering site management and DCT solutions to pharma/biotech sponsors; competing at the top of the market for multi-region Phase 2–4 contracts.
Emerging players
- Science 37: DCT-native platform that enables fully decentralized trials; overlapping with IMA's decentralized trial offering but reaching patients via telehealth rather than physical sites.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Diagnostics Research Group social profiles
Digital presenceDiagnostics Research Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diagnostics Research Group leadership team
Management profileNumber of profiles
Profiles1 record
Diagnostics Research Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diagnostics Research Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diagnostics Research Group
What does Diagnostics Research Group do?
Diagnostics Research Group operates the IMA Clinical Research Network, a flexible clinical trial network that conducts site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs across multiple therapeutic areas including depression, obesity, MASH (metabolic liver disease), and memory loss. The network spans 15+ satellite sites and 150+ total locations in the U.S., supported by a 400K+ patient database with 10K+ unique weekly visits and deployable patient outreach centers.
Is Diagnostics Research Group a public or private company?
Diagnostics Research Group is a private company. It is classified as unknown and is currently operating.
When was Diagnostics Research Group founded?
Diagnostics Research Group was founded in 2000. It employs 11 to 50 people.
Where is Diagnostics Research Group based?
Diagnostics Research Group is headquartered in San Antonio, United States, in the North America region.
How does Diagnostics Research Group make money?
One revenue line is on record: clinical Trial Services Contracts.
Who are Diagnostics Research Group's main competitors?
Direct peers on record are Velocity Clinical Research, CenExel Clinical Research, Flourish Research, DM Clinical Research, Clinical Trials of Texas, Accel Research Sites and Benchmark Research. Broad incumbents are IQVIA (Site Management) and Thermo Fisher Scientific (PPD). Science 37 is listed as an emerging player.
Does Diagnostics Research Group have an API?
No public API is recorded for Diagnostics Research Group.
What industry is Diagnostics Research Group in?
Diagnostics Research Group's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 6215 and its SIC code is 8093.